共 12 条
- [1] Smolen JS(2017)EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update Ann. Rheum. Dis. 76 960-977
- [2] Smolen JS(2010)Treating rheumatoid arthritis to target: recommendations of an international task force Ann. Rheum. Dis. 69 631-637
- [3] Cush JJ(2007)Early rheumatoid arthritis — is there a window of opportunity? J. Rheumatol. Suppl. 80 1-7
- [4] Daien CI(2017)Non-pharmacological and pharmacological interventions in patients with early arthritis: a systematic literature review informing the 2016 update of EULAR recommendations for the management of early arthritis RMD Open 3 e000404-731
- [5] Hua C(2016)Changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studies BMC Musculoskelet. Disord. 17 44-739
- [6] Combe B(2017)Patients with early rheumatoid arthritis in the 2000s have equal disability and pain despite less disease activity compared with the 1990s: data from the BARFOT Study over 8 years J. Rheumatol. 44 723-undefined
- [7] Landewe R(2017)Decreased cardiovascular mortality in patients with incident rheumatoid arthritis (RA) in recent years: dawn of a new era in cardiovascular disease in RA? J. Rheumatol. 44 732-undefined
- [8] Mian AN(undefined)undefined undefined undefined undefined-undefined
- [9] Andersson ML(undefined)undefined undefined undefined undefined-undefined
- [10] Forslind K(undefined)undefined undefined undefined undefined-undefined